🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#PDIGREE is an adaptive phase 3 trial of patients w/ IMDC intermed/poor risk metastatic #kidneycancer, treated w/ ipi/nivo (step 1) then adapted to response w/ patients w/ PR/SD randomizing to nivo vs nivo/cabo (step 2), CR receiving nivo, & PD receiving cabo. #ASCO25 OncoAlert

Congrats @jadchahoud on the terrific talk👉Ab#4515 ASCO #ASCO25 👉Phase 1b STELLAR-002 study of zanzalintinib + nivo +/- relatlimab in pts w/ ccRCC #kidneycancer 👉ORR 63% w/ zanza+nivo (adding relatlimab does not help), key takeaway👇 OncoAlert UroToday.com @KidneyCAN Sumanta K. Pal, MD, FASCO

Proud to participate in this podcast to talk about how we can accelerate drug development in relapsed/refractory GCT IU Simon Comprehensive Cancer Center IU_UroOnc Indiana University Hematology/Oncology Fellowship Testicular Cancer

Indiana University reception at #ASCO2025 . Proud to work with a fantastic group of past, present, and future colleagues IU Simon Comprehensive Cancer Center Indiana University Hematology/Oncology Fellowship IU_UroOnc Rafat Abonour Christopher Sweeney, MBBS Noah Richardson Robin Zon, MD, FACP, FASCO Ahmad Al-Hader Greg Durm Nasser Hanna Jennifer Schwartz MD FASCO

The testis cancer educational section at #ASCO2025 is going to be great! Come and attend! Hall D1 at 1:15 today June 2/2025. I am honoured to be part of this stellar panel: Dr Einhorn, Dr Haugnes, DrBagrodia

Dr. Anita Turk discusses Advances in Biomarker Based Management in Mets Colorectal Ca IU Simon Comprehensive Cancer Center Indiana University Hematology/Oncology Fellowship Anita Turk

🫁 Happening now at #ASCO25: Nasser Hanna of IU Simon Comprehensive Cancer Center is delivering an impactful presentation titled “End Lung Cancer Now: How to Engage Your Community to Promote Cancer Screening." ⭐ Don't miss this! ➡️ Stay tuned for our coverage: buff.ly/dqYkpql #lcsm

Live from #ASCO25! Our researchers are sharing their latest work and standing proudly by their posters today in Chicago. From lab discoveries to clinical impact, they’re driving cancer research forward. #ResearchCuresCancer ASCO

Dr. Rebecca Hassoun presenting outcomes with salvage high dose chemo and transplant in relapsed GCT based on radiographic vs tumor marker progression Rebecca Hassoun IU Simon Comprehensive Cancer Center Indiana University Hematology/Oncology Fellowship

Stellar IU fellow and future faculty Noah Richardson presenting data on Trop-2 expression in Germ Cell Tumors Noah Richardson IU Simon Comprehensive Cancer Center Indiana University Hematology/Oncology Fellowship #ASCO25

Starting soon! Promises to be a great session on Refining Management in Germ Cell Tumors IU Simon Comprehensive Cancer Center Indiana University Hematology/Oncology Fellowship #ASCO25

Aditya Bagrodia discusses advances in management of patients with stage 2 seminoma DrBagrodia Testicular Cancer UC San Diego Health Moores Cancer Center #ASCO25

Tour de force by Larry Einhorn going over Pitfalls in the Management of Metastatic GCT and wisdom from over 50 years of expertise in treating testicular cancer. And yes the reference for hCG decline was from Robin Zon, MD, FACP, FASCO from IU fellowship IU Simon Comprehensive Cancer Center Indiana University Hematology/Oncology Fellowship Indiana University Department of Urology

Outstanding talk by Dr. Lucia Nappi discussing Management of Post Chemo Masses in Germ Cell Tumors Lucia Nappi #ASCO2025

Fantastic talk going over survivorship issues in patients with Germ Cell Tumors by Dr. Hege Haugnes #ASCO2025

ASCO⁩ #testicularcancer session dripping with wisdom from the one and only Larry Einhorn ⁦Indiana University Department of Urology⁩ ⁦IU Simon Comprehensive Cancer Center⁩ ⁦Lucia Nappi ⁦UBCUrology⁩ #HegeHaugnes ⁦Nabil Adra⁩ ⁦Rana McKay, MD, FASCO⁩ ⁦UC San Diego Health Moores Cancer Center⁩ ⁦UCSD Urology⁩ Team effort!

#ASCO25 #myeloma Aurore Perrot C. Ola Landgren, M.D. Suzanne Lentzsch, MD, PhD Brandon Blue, MD Francesca Gay and Philippe Moreau. The rode to cure? MRD seems to matter. Longer follow up needed. Great studies presented at the oral session.

Congratulations to Shadia Jalal, MD, of the IU Simon Comprehensive Cancer Center, on being named Interim Division Chief for Hematology/Oncology at @IUmedschool.

The annual ASCO Review at IU will be 8 a.m.-2 p.m. Saturday, July 12 at the Marriott Indianapolis Downtown. IU faculty members will provide analysis of the more clinically applicable presentations at this year's ASCO meeting. Learn more: ow.ly/R8v450W8AB1.

An absolute stellar GU oncology section. Looking esp for interest in #GCT! Great team! Great science! Great patient care! And an amazing place to live! Dr. Darren Feldman Nabil Adra Memorial Sloan Kettering Cancer Center IU Simon Comprehensive Cancer Center Uromigos DrTylerStewart